• J J Egea-Guerrero, F Murillo-Cabezas, A Rodríguez-Rodríguez, E Gordillo-Escobar, J Revuelto-Rey, M A Muñoz-Sánchez, A León-Justel, and A Vilches-Arenas.
• Unidad de Neurocríticos, H.U. Virgen del Rocío, IBiS/CSIC Universidad de Sevilla, Sevilla, España. Electronic address: juanjoegea@hotmail.com.
• Med Intensiva. 2014 May 1;38(4):218-25.

ObjectiveTo determine whether a model of transient mass-type brain damage (MTBD) in the rat produces early release of neurospecific enolase (NSE) and protein S100B in peripheral blood, as an expression of the induced brain injury.DesignAn experimental study with a control group.SettingExperimental operating room of the Institute of Biomedicine (IBiS) of Virgen del Rocío University Hospital (Seville, Spain).ParticipantsFourteen adult Wistar rats.InterventionsBlood was sampled at baseline, followed by: MTBD group, a trephine perforation was used to insert and inflate the balloon of a catheter at a rate of 500 μl/20 sec, followed by 4 blood extractions every 20 min. Control group, the same procedure as before was carried out, though without trephine perforation.Primary Study VariablesWeight, early mortality, serum NSE and S100B concentration.ResultsDifferences in NSE and S100B concentration were observed over time within the MTBD group (P<.001), though not so in the control group. With the exception of the baseline determination, differences were observed between the two groups in terms of the mean NSE and S100B values. Following MTBD, NSE and S100B progressively increased at all measurement timepoints, with r=0.765; P=.001 and r=0.628; P=.001, respectively. In contrast, the control group showed no such correlation for either biomarker.ConclusionsSerum NSE and S100B concentrations offer an early indication of brain injury affecting the gray and white matter in an experimental model of mass-type MTBD in the rat.Copyright © 2013 Elsevier España, S.L. and SEMICYUC. All rights reserved.

18 keywords...

hide…